GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation.

about

Precision medicine in diabetes prevention, classification and management.

P2860

Q52677048-6DD50244-CA4C-4695-82F1-0FF9BF594680

P2860

GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation.

Item

http://www.wikidata.org/entity/Q35687357

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation.

@ast

GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation.

@en

type

Item

label

GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation.

@ast

GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation.

@en

prefLabel

GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation.

@ast

GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation.

@en

P1476

GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation.

@en

P2093

Annette Gabriele Ziegler

http://www.w3.org/2001/XMLSchema#string

Gabriele Eder

http://www.w3.org/2001/XMLSchema#string

Ilse Engelsberger

http://www.w3.org/2001/XMLSchema#string

Katharina Warncke

http://www.w3.org/2001/XMLSchema#string

Peter Lohse

http://www.w3.org/2001/XMLSchema#string

Sandra Hermanns

http://www.w3.org/2001/XMLSchema#string

Stefan Burdach

http://www.w3.org/2001/XMLSchema#string

Walter Bonfig

http://www.w3.org/2001/XMLSchema#string

P2860

Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships

Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability

Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus

Structure/function studies of human beta-cell glucokinase. Enzymatic properties of a sequence polymorphism, mutations associated with diabetes, and other site-directed mutants

Mild fasting hyperglycemia in children: high rate of glucokinase mutations and some risk of developing type 1 diabetes mellitus.

Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young.

Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.

Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.

Cell biology assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity.

Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics.

P304

676549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.5402/2011/676549

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221887497

http://www.w3.org/2001/XMLSchema#string

P698

22389783

http://www.w3.org/2001/XMLSchema#string

P932

3263572

http://www.w3.org/2001/XMLSchema#string

GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation.

about

P2860

P2860

GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932